There is an ASX listed Biotech company with an FDA approved product and a market cap of about $36M (at time of writing). Granted, the product is not a cancer treatment, but it is an FDA approved product all the same. That Biotech is also pursuing a treatment for bone marrow cancer myelofibrosis.
So, working in very different fields, but some cheap Biotechs do still exist.
GLTAH.
Analysts Reports (Imugene), page-62
-
- There are more pages in this discussion • 277 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 97 | 7481668 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1703097 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |